Joy Kreeger
Psychiatry · East Aurora, NYNPI 1124122304
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $41,280 of the $53,890 with a category attached, or 76.6%. AbbVie accounts for 83.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $16,660 and has fallen 71.6% since, to $4,724 in 2025. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 952 payments — averaging $56.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$45K
- Lundbeck LLC$3K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$1K
- Neurocrine Biosciences, Inc.$1K
- plus $980 from 8 others
What the payments were for
- Speaking & faculty fees$41,28077%
- Travel & lodging$1550%
- Food & beverage$12,22823%
- Education$2270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 246 | $45,145 |
| Lundbeck LLC | 219 | $2,513 |
| Takeda Pharmaceuticals U.S.A., Inc. | 138 | $1,650 |
| Otsuka America Pharmaceutical, Inc. | 126 | $1,389 |
| Teva Pharmaceuticals USA, Inc. | 73 | $1,119 |
| Neurocrine Biosciences, Inc. | 88 | $1,094 |
| Alfasigma USA, Inc. | 15 | $217 |
| Axsome Therapeutics, Inc. | 13 | $208 |
| Idorsia Pharmaceuticals US Inc | 15 | $172 |
| Johnson & Johnson | 5 | $121 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $120 |
| Alkermes, Inc. | 4 | $73 |
| Neos Therapeutics, LP | 3 | $46 |
| Neuronetics, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$41,901
How this compares
$53,890 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 104 | $74,387 |
| VraylarCariprazine Hcl | 12 | $17,093 |
| Lisdexamfetamine Dimesylate | 16 | $2,407 |
| Vilazodone Hcl | 12 | $1,836 |
| Sertraline Hcl | 34 | $656 |
| Bupropion XlBupropion Hcl | 36 | $625 |
| Clonazepam | 44 | $539 |
| Escitalopram Oxalate | 22 | $359 |
| Bupropion Hcl SrBupropion Hcl | 44 | $357 |
| Trazodone Hcl | 27 | $281 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $275 |
| Bupropion Hcl | 18 | $258 |
| Lamotrigine | 22 | $245 |
| Amitriptyline Hcl | 18 | $165 |
| Duloxetine Hcl | 21 | $151 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $1,650 | $74,387104 claims |
| AbbVieVraylar | $45,145 | $17,09312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,713 psychiatry providers in New York.
Other psychiatry in East Aurora
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Adam AshtonAmherst$1.6M
- Christoph CorrellGlen Oaks$1.5M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
- Jianping ChenNew York$1.2M
- Horacio CapoteAmherst$1.1M
- Yadagiri ChepuruYonkers$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.